Implantable device aims to target pancreatic tumors with fewer side effects
Disease control
Recruiting now
This early-stage study is testing the safety of a new implantable device that delivers chemotherapy directly to pancreatic tumors. The device is placed on the pancreas during surgery and releases the drug gemcitabine locally, aiming to target the cancer more precisely and potenti…
Phase: PHASE1 • Sponsor: Continuity Biosciences, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC